Related Experiment Videos

Tc2 response at the onset of COPD exacerbations

Demosthenes Makris1, Stelios Lazarou1, Michael Alexandrakis2

  • 1Department of Thoracic Medicine, University Hospital, Medical School, University of Larisa, Larisa.

Chest
|May 21, 2008
PubMed

Insights

During COPD exacerbations, CD8+ T cells in sputum increase, while CD4+ T cells and key T cell ratios decrease. This suggests CD8+ cells may drive inflammation during these acute events.

Area of Science:

  • Pulmonology
  • Immunology
  • Respiratory Medicine

Background:

  • CD8+ T lymphocytes play a crucial role in Chronic Obstructive Pulmonary Disease (COPD) pathophysiology.
  • Limited data exists on the specific role of CD8+ T cells during COPD exacerbations.

Purpose of the Study:

  • To prospectively investigate changes in sputum CD8+ T-lymphocyte subpopulations during mild COPD exacerbations compared to stable conditions.
  • To gain further insight into the underlying pathophysiology of COPD exacerbations.

Main Methods:

  • Induced sputum samples were collected from 24 COPD patients during mild exacerbations and stable periods.
  • Flow cytometry and immunocytochemistry were used to measure inflammatory cells and T-lymphocyte subpopulations (CD4+, CD8+, IFN-gamma+, IL-4+).

Main Results:

  • Sputum CD8+ T lymphocytes significantly increased during exacerbations (p < 0.0001).
  • CD4+ T lymphocytes and CD4+/CD8+ ratios significantly decreased during exacerbations (p = 0.0001).
  • Cytokine-producing T cell ratios (IFN-gamma+/IL-4+) also showed significant decreases.

Conclusions:

  • CD8+ lymphocytes are elevated in the airways of COPD patients during exacerbations compared to stable states.
  • These CD8+ cells may exhibit a polarization towards a Tc2 profile during exacerbations.
  • Further research is needed to determine the clinical significance of these findings.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation